DK3500571T3 - Imidazo[1,2-a]pyridinforbindelser, sammensætninger omfattende disse, fremgangsmåder til behandling af sygdomme ved hjælp af disse og fremgangsmåder til fremstilling heraf - Google Patents
Imidazo[1,2-a]pyridinforbindelser, sammensætninger omfattende disse, fremgangsmåder til behandling af sygdomme ved hjælp af disse og fremgangsmåder til fremstilling heraf Download PDFInfo
- Publication number
- DK3500571T3 DK3500571T3 DK17821743.6T DK17821743T DK3500571T3 DK 3500571 T3 DK3500571 T3 DK 3500571T3 DK 17821743 T DK17821743 T DK 17821743T DK 3500571 T3 DK3500571 T3 DK 3500571T3
- Authority
- DK
- Denmark
- Prior art keywords
- imidazo
- diseases
- procedures
- manufacture
- treatment
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000005234 imidazo[1,2-a]pyridines Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662375965P | 2016-08-17 | 2016-08-17 | |
| PCT/US2017/047088 WO2018038988A2 (en) | 2016-08-17 | 2017-08-16 | Compounds, compositions, methods for treating diseases, and methods for preparing compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3500571T3 true DK3500571T3 (da) | 2021-03-08 |
Family
ID=60812120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17821743.6T DK3500571T3 (da) | 2016-08-17 | 2017-08-16 | Imidazo[1,2-a]pyridinforbindelser, sammensætninger omfattende disse, fremgangsmåder til behandling af sygdomme ved hjælp af disse og fremgangsmåder til fremstilling heraf |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220213094A1 (da) |
| EP (2) | EP3854796A1 (da) |
| CA (1) | CA3033755A1 (da) |
| DK (1) | DK3500571T3 (da) |
| ES (1) | ES2862314T3 (da) |
| LT (1) | LT3500571T (da) |
| PL (1) | PL3500571T3 (da) |
| PT (1) | PT3500571T (da) |
| WO (1) | WO2018038988A2 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11542261B2 (en) * | 2016-08-17 | 2023-01-03 | Children's Hospital Medical Center | Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors |
| CA3124088A1 (en) * | 2018-12-20 | 2020-06-25 | Incyte Corporation | Imidazopyridazine and imidazopyridine compounds as inhibitors of activin receptor-like kinase-2 |
| WO2021126779A1 (en) * | 2019-12-18 | 2021-06-24 | The Regents Of The University Of California | Inhibitors of lin28 and methods of use thereof |
| EP4188926A4 (en) * | 2020-07-31 | 2024-08-21 | Children's Hospital Medical Center | Multi-cyclic irak and flt3 inhibiting compounds and uses thereof |
| WO2022140647A1 (en) * | 2020-12-23 | 2022-06-30 | Children's Hospital Medical Center | Multi-cyclic irak and flt3 inhibiting compounds and uses thereof |
| IL310425A (en) * | 2021-07-30 | 2024-03-01 | Childrens Hospital Med Ct | Multi-cyclic irak and flt3 inhibiting compounds and uses thereof |
| WO2023116888A1 (zh) * | 2021-12-23 | 2023-06-29 | 杭州多域生物技术有限公司 | 一种五元并六元化合物、制备方法、药物组合物和应用 |
| AU2023283393A1 (en) * | 2022-06-10 | 2025-01-02 | Interline Therapeutics, Inc. | Imidazo(1,2-a)pyridine derivatives as ripk2 inhibitors |
| WO2023250431A2 (en) * | 2022-06-22 | 2023-12-28 | Children's Hospital Medical Center | Multi-cyclic irak and flt3 inhibiting compounds and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015076800A1 (en) * | 2013-11-21 | 2015-05-28 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine bmi-1 inhibitors |
-
2017
- 2017-08-16 EP EP20211957.4A patent/EP3854796A1/en not_active Withdrawn
- 2017-08-16 PT PT178217436T patent/PT3500571T/pt unknown
- 2017-08-16 LT LTEP17821743.6T patent/LT3500571T/lt unknown
- 2017-08-16 ES ES17821743T patent/ES2862314T3/es active Active
- 2017-08-16 EP EP17821743.6A patent/EP3500571B1/en active Active
- 2017-08-16 PL PL17821743T patent/PL3500571T3/pl unknown
- 2017-08-16 DK DK17821743.6T patent/DK3500571T3/da active
- 2017-08-16 WO PCT/US2017/047088 patent/WO2018038988A2/en not_active Ceased
- 2017-08-16 CA CA3033755A patent/CA3033755A1/en active Pending
-
2022
- 2022-01-04 US US17/568,023 patent/US20220213094A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT3500571T (pt) | 2021-03-29 |
| EP3500571B1 (en) | 2020-12-30 |
| CA3033755A1 (en) | 2018-03-01 |
| WO2018038988A2 (en) | 2018-03-01 |
| PL3500571T3 (pl) | 2021-06-28 |
| US20220213094A1 (en) | 2022-07-07 |
| WO2018038988A3 (en) | 2018-04-05 |
| EP3500571A2 (en) | 2019-06-26 |
| ES2862314T3 (es) | 2021-10-07 |
| EP3854796A1 (en) | 2021-07-28 |
| LT3500571T (lt) | 2021-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3500571T3 (da) | Imidazo[1,2-a]pyridinforbindelser, sammensætninger omfattende disse, fremgangsmåder til behandling af sygdomme ved hjælp af disse og fremgangsmåder til fremstilling heraf | |
| EP3873900C0 (en) | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS INTEGRIN ALPHA4BETA7 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK3697784T3 (da) | Imidazo[4,5-b]pyridinforbindelser og farmaceutiske sammensætninger deraf til behandling af inflammatoriske forstyrrelser | |
| DK3173092T3 (da) | Rna-holdig sammensætning til behandling af tumorsygdomme | |
| IL264156A (en) | Compounds, preparations and methods for treating the disease | |
| DK3478679T3 (da) | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme | |
| DK3445451T3 (da) | Sammensætninger og fremgangsmåder til behandling af lysosomale lagringssygdomme og sygdomme kendetegnet ved lysosomal dysfunktion | |
| DK3230298T3 (da) | 3-substituerede 5-amino-6H-thiazolo[4,5-d]pyrimidin-2,7-dion forbindelser til behandling og forebyggelse af virusinfektion | |
| DK3348557T3 (da) | Imidazo[1,2-a]pyridiner til behandling eller forebyggelse af hyperurekæmi eller gigt | |
| DK3481827T3 (da) | Imidazo[1,2-a]pyridinderivater, fremgangsmåder til fremstilling og anvendelse deraf | |
| IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
| EP3321271A4 (en) | PROCESS FOR THE PRODUCTION OF THE 7H-PYROLLO [2,3-D] PYRIMIDINE DERIVATIVE AND THE CORRESPONDING INTERMEDIATE | |
| EP3256438A4 (en) | Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases | |
| EP3250572A4 (en) | Substituted imidazo [1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3328864T3 (da) | Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser | |
| IL325567A (en) | Methods of treatment using anti-il-17a/f antibodies | |
| DK3242888T3 (da) | Opløselige fgfr3-atrapper til behandling af skeletvækstforstyrrelser | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| DK3395817T3 (da) | Pyrido[1,2-a]pyrimidonanalog, krystalform deraf, mellemprodukt deraf og fremgangsmåde til fremstilling deraf | |
| DK3506901T3 (da) | Anvendelse af kynurensyre til behandling af muskelatrofi | |
| DK3169405T3 (da) | Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme |